The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cellular Oncology

• Publication date

  2013-08-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s13402-013-0142-8PMID 23928726PMCID PMC13012205
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oxidants, antioxidants and the current incurability of metastatic cancers

  2013cited by this paper
• Functional OCT4-specific CD4+ and CD8+ T cells in healthy controls and ovarian cancer patients

  2013cited by this paper
• Natural killer cells preferentially target cancer stem cells; role of monocytes in protection against NK cell mediated lysis of cancer stem cells.

  2012cited by this paper
• Targeting cancer stem cells: a new therapy to cure cancer patients.

  2012cited by this paper
• Identification of a Potential Ovarian Cancer Stem Cell Gene Expression Profile from Advanced Stage Papillary Serous Ovarian Cancer

  2012cited by this paper
• Cancer stem cells: current status and evolving complexities.

  2012cited by this paper
• A molecular beacon-based method for screening cervical cancer.

  2012cited by this paper
• Targeting the cancer initiating cell: the ultimate target for cancer therapy.

  2012cited by this paper
• Nanog signaling in cancer promotes stem-like phenotype and immune evasion.

  2012cited by this paper
• Intratumoral Heterogeneity in the Self‐Renewal and Tumorigenic Differentiation of Ovarian Cancer

  2012cited by this paper
• Ovarian cancer stem cells and inflammation

  2011influential reference
• Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.

  2011cited by this paper
• Expression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinoma

  2011cited by this paper
• Eradicating cancer cells: struggle with a chameleon

  2011cited by this paper
• Targeting the Mitochondria Activates Two Independent Cell Death Pathways in Ovarian Cancer Stem Cells

  2011cited by this paper
• Distinct types of tumor-initiating cells form human colon cancer tumors and metastases.

  2011cited by this paper
• c-Myc Regulates Self-Renewal in Bronchoalveolar Stem Cells

  2011cited by this paper
• Analysis of Epithelial and Mesenchymal Markers in Ovarian Cancer Reveals Phenotypic Heterogeneity and Plasticity

  2011cited by this paper
• Cancer Cells Cyclically Lose and Regain Drug-Resistant Highly Tumorigenic Features Characteristic of a Cancer Stem-like Phenotype

  2011cited by this paper
• Long-Term Sphere Culture Cannot Maintain a High Ratio of Cancer Stem Cells: A Mathematical Model and Experiment

  2011cited by this paper
• Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells

  2011cited by this paper
• Cytokine analysis as a tool to understand tumour-host interaction in ovarian cancer.

  2011cited by this paper
• The cancer stem cell: premises, promises and challenges

  2011cited by this paper
• Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers

  2010cited by this paper
• Isolation of Stem Cells from Human Pancreatic Cancer Xenografts

  2010cited by this paper
• The role of cancer stem cells and the side population in epithelial ovarian cancer.

  2010cited by this paper
• Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer

  2010cited by this paper
• The role of tumor initiating cells in drug resistance of breast cancer: Implications for future therapeutic approaches.

  2010cited by this paper
• Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized.

  2010cited by this paper
• The therapeutic promise of the cancer stem cell concept.

  2010cited by this paper
• myc maintains embryonic stem cell pluripotency and self-renewal.

  2010cited by this paper
• A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.

  2010cited by this paper
• Expression Compilation of Several Putative Cancer Stem Cell Markers by Primary Ovarian Carcinoma

  2010cited by this paper
• CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells

  2010cited by this paper
• Natural immunity to pluripotency antigen OCT4 in humans

  2010cited by this paper
• ALDH1 Expression Correlates with Favorable Prognosis in Ovarian Cancers

  2009cited by this paper
• CD133 antigen expression in ovarian cancer

  2009cited by this paper
• IL-6-induced stimulation of c-myc translation in multiple myeloma cells is mediated by myc internal ribosome entry site function and the RNA-binding protein, hnRNP A1.

  2008cited by this paper
• Ovarian cancer plasticity and epigenomics in the acquisition of a stem-like phenotype

  2008cited by this paper
• OCT4 and NANOG are the key genes in the system of pluripotency maintenance in mammalian cells

  2008cited by this paper
• Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research

  2008cited by this paper
• CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors.

  2008cited by this paper
• Requirement of Nanog dimerization for stem cell self-renewal and pluripotency

  2008cited by this paper
• Identification and characterization of ovarian cancer-initiating cells from primary human tumors.

  2008cited by this paper
• ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

  2007cited by this paper
• Phenotypic characterization of human colorectal cancer stem cells

  2007cited by this paper
• Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

  2006cited by this paper
• The Human OCT-4 Isoforms Differ in Their Ability to Confer Self-renewal*

  2006cited by this paper
• POU5F1 Isoforms Show Different Expression Patterns in Human Embryonic Stem Cells and Preimplantation Embryos

  2006cited by this paper
• Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness.

  2006cited by this paper
• Nanostructured Probes for RNA Detection in Living Cells

  2006cited by this paper
• Oct4 pseudogenes are transcribed in cancers.

  2005cited by this paper
• A tumorigenic subpopulation with stem cell properties in melanomas.

  2005cited by this paper
• Therapeutic implications of cancer stem cells.

  2004cited by this paper
• Identification of a Nuclear Localization Signal in OCT4 and Generation of a Dominant Negative Mutant by Its Ablation*

  2004cited by this paper
• Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis.

  2004cited by this paper
• Prospective identification of tumorigenic breast cancer cells

  2003cited by this paper
• The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells.

  2003cited by this paper
• POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors.

  2003cited by this paper
• Identification of a cancer stem cell in human brain tumors.

  2003cited by this paper
• Adult stem cell plasticity: new pathways of tissue regeneration become visible.

  2002cited by this paper
• Human embryonic genes re-expressed in cancer cells

  2001cited by this paper
• c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover.

  2000cited by this paper
• Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

  1997cited by this paper
• Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell.

  1996cited by this paper
• Identification of the human c-myc protein nuclear translocation signal

  1988cited by this paper

• Expression of Oct3/4 isoforms and its association with the risk of relapse in acute lymphoblastic leukemia

  2025cites this paper
• Deciphering Common Traits of Breast and Ovarian Cancer Stem Cells and Possible Therapeutic Approaches

  2023cites this paper
• Comprehensive Overview the Role of Glycosylation of Extracellular Vesicles in Cancers

  2023cites this paper
• Polyphyllin VII is a Potential Drug Targeting CD44 Positive Colon Cancer Cells.

  2022cites this paper
• Polyphyllin VII as a potential drug for targeting stemness in hepatocellular cancer via STAT3 signaling.

  2022cites this paper
• Effect of ALDH1A1 Gene Knockout on Drug Resistance in Paclitaxel and Topotecan Resistant Human Ovarian Cancer Cell Lines in 2D and 3D Model

  2022cites this paper
• Cancer Stem Cells in Ovarian Cancer—A Source of Tumor Success and a Challenging Target for Novel Therapies

  2022cites this paper
• Clinical application and pharmacological mechanism of Wuling powder in the treatment of ascites: A systematic review and network pharmacological analysis.

  2021cites this paper
• Loss of Krüppel‐like factor 9 facilitates stemness in ovarian cancer ascites‐derived multicellular spheroids via Notch1/slug signaling

  2021cites this paper
• The Embryonic Key Pluripotent Factor NANOG Mediates Glioblastoma Cell Migration via the SDF1/CXCR4 Pathway

  2021cites this paper
• Screening Therapeutic Agents Specific to Breast Cancer Stem Cells Using a Microfluidic Single-Cell Clone-Forming Inhibition Assay.

  2020cites this paper
• How to win the ovarian cancer stem cell battle: destroying the roots

  2020cites this paper
• Association of ALDH1A1-NEK-2 axis in cisplatin resistance in ovarian cancer cells

  2020cites this paper
• Signaling pathways and microRNAs, the orchestrators of NANOG activity during cancer induction.

  2020cites this paper
• Stem Cells in Ovarian Cancer and Potential Therapies

  2020cites this paper
• Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer

  2020cites this paper
• PER2 inhibits proliferation and stemness of glioma stem cells via the Wnt/β-catenin signaling pathway

  2020cites this paper
• Recent Advances in Cancer Plasticity: Cellular Mechanisms, Surveillance Strategies, and Therapeutic Optimization

  2020cites this paper
• Stimulative role of ST6GALNAC1 in proliferation, migration and invasion of ovarian cancer stem cells via the Akt signaling pathway

  2019cites this paper
• Association of Single-Nucleotide Polymorphism REX1 rs6815391, OCT4 rs13409 or rs3130932, and CTBP2 rs3740535 with Primary Lung Cancer Susceptibility: A Case-Control Study in a Chinese Population

  2019cites this paper
• MicroRNA-23a depletion promotes apoptosis of ovarian cancer stem cell and inhibits cell migration by targeting DLG2

  2019cites this paper
• Association of Single-Nucleotide Polymorphism REX 1 rs 6815391 , OCT 4 rs 13409 or rs 3130932 , and CTBP 2 rs 3740535 with Primary Lung Cancer Susceptibility : A Case-Control Study in a Chinese Population

  2019cites this paper
• Presence and role of stem cells in ovarian cancer

  2019cites this paper
• ZnAs@SiO2 nanoparticles as a potential anti-tumor drug for targeting stemness and epithelial-mesenchymal transition in hepatocellular carcinoma via SHP-1/JAK2/STAT3 signaling

  2019cites this paper
• Ovarian Cancer Stem Cell Heterogeneity.

  2019cites this paper
• SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinoma.

  2019cites this paper
• Glycosylation of ascites-derived exosomal CD133: a potential prognostic biomarker in patients with advanced pancreatic cancer

  2019cites this paper
• Immune Curbing of Cancer Stem Cells by CTLs Directed to NANOG

  2018cites this paper
• STON2 negatively modulates stem-like properties in ovarian cancer cells via DNMT1/MUC1 pathway

  2018cites this paper
• Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?

  2018cites this paper
• Epithelial plasticity and cancer stem cells: Major mechanisms of cancer pathogenesis and therapy resistance

  2017cites this paper
• PGC1α induced by reactive oxygen species contributes to chemoresistance of ovarian cancer cells

  2017cites this paper
• Ovarian cancer stem cells: still an elusive entity?

  2017cites this paper
• Different Genotype of rs3130932 Single Nucleotide Polymorphism Between Gastric Cancer Patients and Normal Subjects

  2017cites this paper
• Verrucarin J inhibits ovarian cancer and targets cancer stem cells

  2017cites this paper
• Ovarian Cancer Stem Cells: Unraveling a Germline Connection

  2017cites this paper
• The Role of Stem Cells in Ovarian Cancer : A Review

  2016cites this paper
• Oct4B, CD90, and CD73 are upregulated in bladder tissue following electro-resection of the bladder

  2016cites this paper
• Erratum to: Glycogen synthase kinase 3 (GSK3)-inhibitor SB216763 promotes the conversion of human umbilical cord mesenchymal stem cells into neural precursors in adherent culture

  2016cites this paper
• NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer

  2016cites this paper
• Elevated ZEB 2 and c-myc expression and their clinical significance in the epithelial ovarian cancer

  2016cites this paper
• Glycogen synthase kinase 3 (GSK3)-inhibitor SB216763 promotes the conversion of human umbilical cord mesenchymal stem cells into neural precursors in adherent culture

  2016cites this paper
• Cancer stem cells (CSCs), cervical CSCs and targeted therapies

  2016cites this paper
• HepG2 cells acquire stem cell-like characteristics after immune cell stimulation

  2015cites this paper
• IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3′-diindolylmethane in ovarian cancer cells

  2015cites this paper
• Metformin and epithelial ovarian cancer therapeutics

  2015cites this paper
• Cellular immunotherapy in ovarian cancer: Targeting the stem of recurrence.

  2015cites this paper
• The bone marrow metastasis niche in retinoblastoma

  2015cites this paper
• High expression of OCT4 is frequent and may cause undesirable treatment outcomes in patients with acute myeloid leukemia

  2015cites this paper
• A critical role of Oct 4 A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer

  2015cites this paper
• MicroRNAs与OCT4基因之间的相互作用

  2015cites this paper
• NF-κB signaling in cancer stem cells: a promising therapeutic target?

  2015cites this paper
• Expression of c-myc and mutation of the KRAS gene in patients with ovarian mucinous tumors.

  2015cites this paper
• Ca2+/calmodulin-dependent protein kinase IIγ enhances stem-like traits and tumorigenicity of lung cancer cells

  2015cites this paper
• A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer

  2015cites this paper
• CONSORT: Sam68 Is Directly Regulated by MiR-204 and Promotes the Self-Renewal Potential of Breast Cancer Cells by Activating the Wnt/Beta-Catenin Signaling Pathway

  2015cites this paper
• 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) inhibits human ovarian cancer cell proliferation

  2014cites this paper
• Coexpression of HMGA2 and Oct4 predicts an unfavorable prognosis in human gastric cancer

  2014cites this paper
• Identification and Characterization of Bronchioalveolar Stem Cells and Oct 4 Positive Cells in Adult Mouse Lung

  2014cites this paper
• ARID3B increases ovarian tumor burden and is associated with a cancer stem cell gene signature

  2014cites this paper
• Canine Epidermal Neural Crest Stem Cells: Characterization and Potential as Therapy Candidate for a Large Animal Model of Spinal Cord Injury

  2014cites this paper
• c-Myc (Myc) and cancer literatures

  2014cites this paper
• Epithelial to mesenchymal transition and the cancer stem cell phenotype: Insights from cancer biology with therapeutic implications for colorectal cancer

  2014cites this paper